What if the focus turned from sacrificing quality for cost within logistics services, towards optimizing trial duties and VAT to recoup clinical trial services spend?
TORONTO (PRWEB)
November 16, 2021
The global clinical trial supply and logistics market continues to grow, to support increasing pharma R&D spend. With this growth comes the continued drive to reduce cost in the supply chain, in a context in which the logistics are becoming more complex due to product sourcing requirements, temperature control, local regulatory requirements and decentralized trial set up.
What if the focus turned from sacrificing quality for cost within logistics services, towards optimizing trial duties and VAT to recoup clinical trial services spend?
Register for this webinar to learn more as we discuss cost optimization strategies and for practical advice including:
-
How VAT and duties appear in the budgets of clinical trials - What is claimable/non-reclaimable per country
- Duty and VAT per country
- Bottlenecks, and how to resolve them
- Cost reduction case studies
Join Denis Volkov, Sales Director at Oximio, for the live webinar on Tuesday, November 23, 2021 at 9am EST (2pm GMT/UK).
For more information, or to register for this event, visit How to Optimize Customs Taxes for Clinical Trials in Eastern Europe.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Share article on social media or email: